View source for TRIGLIDE contraindications

__NOTOC__
{{Fenofibrate}}
{{CMG}}; {{AE}} {{SS}}

==Contraindications==
Antara is contraindicated in:

*patients with severe [[renal impairment]], including those receiving dialysis [see Clinical Pharmacology (12.3) ].
*patients with active liver disease, including those with primary biliary cirrhosis and unexplained persistent liver function abnormalities [see Warnings and Precautions (5.3) ].
*patients with pre-existing gallbladder disease [see Warnings and Precautions (5.5) ].
*nursing mothers [see Use in Specific Populations (8.3) ].
*patients with known [[hypersensitivity ]]to [[fenofibric acid]] or fenofibrate [see Warnings and Precautions (5.9) ].<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TRIGLIDE (FENOFIBRATE) TABLET [SHIONOGI INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=94a4a99b-24df-4e81-b409-5325d36647d2#nlm34067-9 | publisher =  | date =  | accessdate = 12 February 2014 }}</ref>
==References==

{{Reflist|2}} 

{{Lipid modifying agents}}
{{Antigout preparations}}

[[Category:Fibrates]]
[[Category:Prodrugs]]
[[Category:Organochlorides]]
[[Category:Benzophenones]]
[[Category:Phenol ethers]]
[[Category:Carboxylate esters]]